	Ebitda		Date
Alnylam Pharmaceuticals	USD 381.78M	362.95M	2025-09
Chugai Pharma	JPY 169.01B	12.52B	2025-12
Daiichi Sankyo	JPY 101.6B	22.81B	2025-03
DBV Technologies	USD -33.48M	5.55M	2025-09
Gilead Sciences	USD 4.03B	628M	2025-09
GlaxoSmithKline	GBP 3.36B	179M	2025-09
Glaxosmithkline	GBP 4.75B	1.52B	2025-09
Incyte	USD 506.92M	74.6M	2025-09
Ionis Pharmaceuticals	USD -157.12M	307.36M	2025-09
Karyopharm Therapeutics	USD -26.2M	1.83M	2024-09
Neurocrine Biosciences	USD 246.7M	93.8M	2025-09
Novavax	USD -117.12M	55.66M	2024-09
PTC Therapeutics	USD -33.11M	1B	2025-06
Regeneron Pharmaceuticals	USD 1.92B	261.9M	2025-09
Roche Holding	CHF 12.68B	2.36B	2024-06
Sarepta Therapeutics	USD 126.42M	416.82M	2025-06
Ultragenyx Pharmaceutical	USD -91.34M	35.09M	2025-06
Vertex Pharmaceuticals	USD 1.44B	100.4M	2025-09

BioCryst Pharmaceuticals - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.